Inverse association between microRNA-124a and ABCC4 in HepG2 cells treated with antiretroviral drugs

References

• Abla N, Chinn LW, Nakamura T, et al (2008). The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther 325:859–68
   PubMed Web of Science ®Google Scholar
• Aleksunes LM, Campion SN, Goedken MJ, Manautou JE. (2008). Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci 104:261–73
   PubMed Web of Science ®Google Scholar
• Anderson PL, Lamba J, Aquilante CL, et al (2006). Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. JAIDS 42:441–9
   Google Scholar
• Begriche K, Massart J, Robin MA, et al (2011). Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol 54:773–94
   PubMed Web of Science ®Google Scholar
• Borel F, Han R, Visser A, et al (2012). Adenosine triphosphate‐binding cassette transporter genes up‐regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 55:821–32
   PubMed Web of Science ®Google Scholar
• Bort R, Ponsoda X, Jover R, et al (1999). Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. J Pharmacol Exp Ther 288:65–72
   PubMed Web of Science ®Google Scholar
• Brinkman K, Ter Hofstede HJ, Burger DM, et al (1998). Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. Aids 12:1735–44
   PubMed Web of Science ®Google Scholar
• Chai J, Luo D, Wu X, et al (2011). Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis. J Gastrointest Surg 15:996–1004
   PubMed Web of Science ®Google Scholar
• Chen ZS, Lee K, Walther S, et al (2002). Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res 62:3144–50
   PubMed Web of Science ®Google Scholar
• Chuturgoon AA, Phulukdaree A, Moodley D. (2014). Fumonisin B1 modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b. Toxicol Lett 227:50–5
   PubMed Web of Science ®Google Scholar
• Doring B, Petzinger E. (2014). Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism. Drug Metab Rev 46:261–82
   Google Scholar
• Hasegawa M, Kusuhara H, Adachi M, et al (2007). Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. J Am Soc Nephrol 18:37–45
   PubMed Web of Science ®Google Scholar
• Imaoka T, Kusuhara H, Adachi M, et al (2007). Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Molec Pharmacol 71:619–27
   PubMed Web of Science ®Google Scholar
• Ivanov M, Barragan I, Ingelman-Sundberg M. (2014). Epigenetic mechanisms of importance for drug treatment. Trends Pharmacol Sci 35:384–96
   PubMed Web of Science ®Google Scholar
• Li X, Pan YZ, Seigel GM, et al (2011). Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2 + cancer cells. Biochem Pharmacol 81:783–92
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 − ΔΔCT method. Methods 25:402–8
   PubMed Web of Science ®Google Scholar
• Maher JM, Dieter MZ, Aleksunes LM, et al (2007). Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway. Hepatology 46:1597–610
   PubMed Web of Science ®Google Scholar
• Markova SM, Kroetz DL. (2014). ABCC4 is regulated by microRNA-124a and microRNA-506. Biochem Pharmacol 87:515–22
   PubMed Web of Science ®Google Scholar
• Mentzel CMJ, Anthon C, Jacobsen MJ, et al (2015). Gender and obesity specific microRNA expression in adipose tissue from lean and obese pigs. PLoS One 10:e0131650
   Google Scholar
• Nagiah S, Phulukdaree A, Chuturgoon A. (2015). Mitochondrial and oxidative stress response in HepG2 cells following acute and chronic exposure to antiretroviral drugs. J Cell Biochem 116:1939–46
   PubMed Web of Science ®Google Scholar
• Phulukdaree A, Moodley D, Khan S, Chuturgoon AA. (2015). Atorvastatin increases miR-124a expression: a mechanism of Gamt modulation in liver cells. J Cell Biochem 116:2620–7
   PubMed Web of Science ®Google Scholar
• Ramirez CM, Dávalos A, Goedeke L, et al (2011). MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31:2707–14
   PubMed Web of Science ®Google Scholar
• Reid G, Wielinga P, Zelcer N, et al (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci 100:9244–9
   PubMed Web of Science ®Google Scholar
• Rius M, Nies AT, Hummel-Eisenbeiss J, et al (2003). Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38:374–84
   PubMed Web of Science ®Google Scholar
• Smith RP, Lam ET, Markova S, et al (2012). Pharmacogene regulatory elements: from discovery to applications. Genome Med 4:45
   PubMed Web of Science ®Google Scholar
• Tian Q, Zhang J, Chan SY, et al (2006). Topotecan is a substrate for multidrug resistance associated protein 4. Curr Drug Metab 7:105–18
   PubMed Web of Science ®Google Scholar
• Tian Q, Zhang JTANTMC, Chan E, et al (2005). Human multidrug resistance associated protein 4 confers resistance to camptothecins. Pharmaceut Res 22:1837–53
   PubMed Web of Science ®Google Scholar
• Venhoff N, Setzer B, Melkaoui K, Walker UA. (2007). Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antiviral Ther 12:1075
   PubMed Web of Science ®Google Scholar
• Walker UA, Setzer B, Venhoff N. (2002). Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. Aids 16:2165–73
   PubMed Web of Science ®Google Scholar
• Wielinga PR, Van Der Heijden I, Reid G, et al (2003). Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278:17664–71
   PubMed Web of Science ®Google Scholar
• Xu S, Weerachayaphorn J, Cai SY, et al (2010). Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. Am J Physiol-Gastrointest Liver Physiol 299:G126–35
   PubMed Web of Science ®Google Scholar
• Yu AM. (2009). Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 5:1513–28
   PubMed Web of Science ®Google Scholar
• Zelcer N, Reid G, Wielinga P, et al (2003). Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 371:361–7
   PubMed Web of Science ®Google Scholar